Advancements in Genomic Testing and Board Examination Insights for Thymoma

This chapter delves into how next-generation sequencing (NGS) enhances our understanding and treatment of advanced thymoma by highlighting genomic differences between primary tumors and metastases. It also considers potential exam topics, prioritizing biological aspects over treatment controversies.